News for SRGA Stock

Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023 Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023 Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023 Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO Portal Surgical Guidance System Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Surgalign Announces $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Surgalign™ Announces Corporate Restructuring Program to Focus on Key Growth Areas Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022 Surgalign™ Awarded 2022 Best New Technology Award from Orthopedics This Week for its HOLO Portal™ Surgical Guidance System Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc. Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range Surgalign Names Paolo Amoruso Chief Legal Officer and Corporate Secretary Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019 Surgalign Schedules Second Quarter 2022 Earnings Release for August 9, 2022 Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign™ Announces the First Successful Surgical Procedure Utilizing its HOLO Portal™ Surgical Guidance System Surgalign Holdings, Inc. Schedules First Quarter 2022 Earnings Release for May 10, 2022 Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results Surgalign Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release for March 15, 2022 Surgalign Announces Appointment of David Lyle as Chief Financial Officer Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. Announces Pricing of $20 Million Public Offering Surgalign Holdings, Inc. Announces Proposed Public Offering Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc. Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference Surgalign Holdings, Inc. Announces Third Quarter 2021 Results Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. Schedules Third Quarter 2021 Earnings Release for November 9, 2021 Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings Announces Management Changes Surgalign Appoints Sheryl Conley as Chair of the Board of Directors Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation Surgalign Holdings, Inc. Announces Second Quarter 2021 Results Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. Schedules Second Quarter 2021 Earnings Release for August 6, 2021 Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference Surgalign Holdings, Inc. Announces Closing of $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules Surgalign Holdings, Inc. Announces $50 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules Surgalign Holdings Announces Collaboration with Inteneural Networks, a Leading Developer of Artificial Intelligence for Clinical Neurosciences Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. to Participate at the Craig-Hallum Institutional Investor Conference Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Surgalign Holdings, Inc. Announces First Quarter 2021 Results Surgalign Submits Premarket Notification 510(k) of Its Digital Surgical Guidance System Surgalign Adds Medical Device Prototyping and Manufacturing Facility in San Diego Surgalign Holdings, Inc. Schedules First Quarter 2021 Earnings Release for May 10, 2021 Surgalign Appoints Marc Mackey as Executive Vice President, Digital Surgery Surgalign Holdings, Inc. Announces Agreement to Acquire Holo Surgical Inc. and its ARAI™ Digital Surgery Platform Surgalign Holdings, Inc. to Present at the Sidoti Virtual Investor Conference Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2020 Results and Introduces 2021 Guidance Surgalign Holdings, Inc. Announces Date Change for Fourth Quarter and Full Year 2020 Earnings Release and Conference Call Surgalign Holdings Schedules Fourth Quarter and Full Year 2020 Earnings Call for March 11, 2021 Surgalign Holdings, Inc. Announces Record Date and Annual Meeting Date Surgalign Holdings, Inc. Announces Pricing of Public Offering of 25,000,000 Shares of its Common Stock Surgalign Holdings Announce the Commercial Launch of ViBone® Moldable and the First Clinical Implantation Surgalign Holdings, Inc. to Participate at the 23rd Annual ICR/Westwicke Conference Surgalign Holdings, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Surgalign Holdings, Inc. Appoints Paul Lewicki, PhD to Board of Directors Surgalign Holdings, Inc. Announces Third Quarter 2020 Results Surgalign Holdings, Inc. Schedules Third Quarter 2020 Earnings Release for November 11, 2020 Surgalign Holdings, Inc. Announces Date Change for Third Quarter 2020 Earnings Release and Conference Call Surgalign Holdings, Inc. Schedules Third Quarter 2020 Earnings Call for November 6 and Virtual Investor Day for November 12, 2020 Surgalign Holdings, Inc. Announces Completion of Acquisition of Holo Surgical Inc. and its ARAI Digital Surgery Platform Surgalign Holdings, Inc. Announces Agreement to Acquire Holo Surgical Inc. and its ARAI™ Digital Surgery Platform Surgalign Holdings, Inc. to Present at the Sidoti Small Cap Virtual Conference Surgalign Holdings, Inc. to Present at the Cantor Virtual Global Healthcare Conference Surgalign Names Douglas S. Bireley, Executive Vice President, Marketing and Research & Development Surgalign Holdings, Inc. Schedules Second Quarter 2020 Earnings Call for August 4, 2020